BioMarin Pharmaceutical Inc. (FRA:BM8)
Germany
· Delayed Price · Currency is EUR 45.98
-0.37 (-0.80%)
At close: Dec 5, 2025
BioMarin Pharmaceutical Employees
BioMarin Pharmaceutical had 3,040 employees as of December 31, 2024. The number of employees decreased by 361 or -10.61% compared to the previous year.
Employees
3,040
Change (1Y)
-361
Growth (1Y)
-10.61%
Revenue / Employee
€867,440
Profits / Employee
€145,905
Market Cap
8.82B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 318,000 |
| Allianz SE | 156,626 |
| Deutsche Telekom AG | 198,194 |
| Siemens Energy AG | 103,000 |
| Rheinmetall AG | 28,539 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
BioMarin Pharmaceutical News
- 2 days ago - BMRN Experiences Downgrade and Price Target Cut by Leerink Partners | BMRN Stock News - GuruFocus
- 17 days ago - BioMarin Pharmaceutical Inc. (BMRN) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 24 days ago - BioMarin to Participate at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 10:30 AM GMT in London, England - PRNewsWire
- 25 days ago - BMRN February 2026 Options Begin Trading - Nasdaq
- 4 weeks ago - BioMarin Pharmaceutical (BMRN) Downgraded by Stifel: Target Price Lowered | BMRN Stock News - GuruFocus
- 5 weeks ago - BioMarin (BMRN) Achieves FDA Priority Review for Expanded Use of Palynziq - GuruFocus
- 5 weeks ago - FDA Accepts BioMarin's PALYNZIQ® (pegvaliase-pqpz) Supplemental Biologics License Application for Priority Review to Expand Use to Adolescents Aged 12-17 with Phenylketonuria - PRNewsWire
- 5 weeks ago - Beyond the Balance Sheet: What SWOT Reveals About BioMarin Pharmaceutical Inc (BMRN) - GuruFocus